Predictive Oncology Inc. Recorded Big Gain
Predictive Oncology Inc. (POAI:NASDAQ) jumped higher at $0.49, a gain of 77.9%. On Thu, Apr 13, 2023, POAI:NASDAQ touched a New 2-Week High of $0.49. The stock appeared on our News Catalysts scanner on Tue, Apr 04, 2023 at 09:28 AM in the 'MISCELLANEOUS' category. From Thu, Mar 30, 2023, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Mon, Feb 06, 2023 at $0.68 with a volume of 1M+.
About Predictive Oncology Inc. (POAI:NASDAQ)
Precision Therapeutics Inc functions in the healthcare domain. It is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. The Company distributes these products to hospitals, surgical centers and other medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented and disposed of.
Top 10 Gainers:
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 345.63%
- Inpixon (INPX:NASDAQ), 128.43%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 97.58%
- Marpai Inc. (MRAI:NASDAQ), 90.29%
- Predictive Oncology Inc. (POAI:NASDAQ), 77.86%
- Auddia Inc. (AUUD:NASDAQ), 67.93%
- Ocean Biomedical Inc Com (OCEA:NASDAQ), 49.89%
- Pulse Biosciences, Inc. (PLSE:NASDAQ), 40.12%
- Consolidated Communications Holdings, Inc. (CNSL:NASDAQ), 38.77%
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 36.97%